[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558174":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":30,"locations":35,"responsibleParty":52,"collaborators":25,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":25,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":25,"enrollmentInfo":65,"targetDuration":25,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":76,"overallStatus":38,"whyStopped":25,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"GROUP 1","ACTIVE_COMPARATOR","1 session of fESWT",[13],"Device: fESWT",{"label":15,"type":16,"description":17,"interventionNames":18},"GROUP 2","EXPERIMENTAL","3 sessions of fESWT (1 session per week for 3 consecutive weeks)",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","fESWT","Shock wave therapy will be applied with Duolith SD1 device (Storz Medical, Tagerwilen, Switzerland). Therapy will be administered in the gastrocnemius medial and lateral and in the soleus muscles.\n\nParameters: 0.15mJ\u002Fmm2, 4-5 Hz, 1500 shoots\u002Fmuscle.",[9,15],null,[27],{"name":28,"affiliation":5,"role":29},"Teresa Mª Mateu Campos","PRINCIPAL_INVESTIGATOR",[31],{"name":28,"role":32,"phone":33,"phoneExt":25,"email":34},"CONTACT","+34666803771","teremateuc@gmail.com",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Hospital de la Plana","RECRUITING","Vila-real","Castellon","12540","Spain","ES",{"type":45,"coordinates":46},"Point",[47,48],-0.10087,39.9383,{"lat":48,"lon":47},[51],{"name":28,"role":32,"phone":33,"phoneExt":25,"email":34},{"type":53,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"SPONSOR_INVESTIGATOR","Teresa Mateu Campos","Principal Investigator","100558174","extracorporeal-shock-wave-therapy-on-spastic-equinus-foot-in-stroke-patients-100558174",false,"NCT06547684","Extracorporeal Shock Wave Therapy on Spastic Equinus Foot in Stroke Patients","Effects of Focused Extracorporeal Shock Wave Therapy on Spastic Equinus Foot in Stroke Patients: a Randomized Controlled Trial","Inclusion Criteria:\n\n* Age greater than 18 years old\n* Time from stroke (ischemic o hemorrhagic) onset of at least 6 months\n* Spastic equinus foot: triceps surae tone grade at least 1+ on the MAS score\n* Ability to walk alone with or without aids\n\nExclusion Criteria:\n\n* Fixed ankle joint contracture\n* Severe medical problems\n* Treatment of the affected leg with botulinum toxin in the las 6 months\n* Cognitive impairment","ALL","18 Years",{"count":66,"type":67},60,"ESTIMATED","INTERVENTIONAL",[70],"NA","The goal of this study is to evaluate long term effects of focused extracorporeal shock wave therapy (fESWT) on triceps surae spasticity in stroke patients according to the number of sessions applied.\n\nHypothesis: 3 sessions of fESWT on equinus foot in stroke patients improve spasticity and functionality for longer term than 1 session of fESWT.",[73,74,75],"Stroke","Equinus Deformity","Spasticity, Muscle",[73,74,77],"Extracorporeal Shock Wave Therapy","2024-09-07",{"date":80,"type":81},"2024-09-19","ACTUAL",{"date":83,"type":81},"2020-08-28",{"date":85,"type":67},"2025-10-31",{"name":54,"class":6},1]